Login to MyHealth
Login to My HealthApplied Molecular Medicine
The USC Center for Applied Molecular Medicine uses proteomic and molecular technologies to better understand cancer and develop personalized therapies. The Center (http://camm.usc.edu) is funded by the National Cancer Institute as part of Center for Cancer Nanotechnology Excellence and by private foundations to develop and apply technology to patients with advanced cancer.
USC Westside Prostate Center
Located in Beverly Hills, the USC Westside Prostate Cancer Center is a multi-disciplinary cancer clinic and clinical trials center. We work to provide care for patients with prostate and other genito-urinary cancers and bring cutting-edge therapies to patients through clinical trials. Our goal is to make the most exciting and promising molecular targeted therapeutics available for our patients. Our team is comprised of USC medical oncologists, radiologists, radiation therapists and urologists.
Center for Applied Molecular Medicine (CAMM) Laboratory
Our CAMM team works to pioneer and apply technology to further develop new targeted therapeutics for genito-urinary cancers and to manage patients with cancer.
The principle goal of our center is the development, validation and application of proteomics technologies for the diagnosis and management of disease. Patients will have biopsies of their tumor, and/or blood/plasma samples interrogated by quantitative protein profiling techniques to discover and establish initial panels of markers of response to a given therapy. Once an initial panel has been constructed, it will direct the treatment course for patients. Samples from these patients may then be used to iteratively refine the existing marker panel and potentially to inform cancer biology and aid in the identification of new targets for the development of novel therapeutic agents. Toward this vision, we are actively applying existing proteomics techniques to clinical and biological samples to better understand the biology of cancer and other diseases. In addition, we are developing new technologies that will allow us to extract more information reproducibly from biological and clinical samples.
